Skip links

Archive

Researchers Share Experiences at 2014 Rochester Drug Discovery Symposium

Researchers Share Experiences at 2014 Rochester Drug Discovery Symposium

in

Four prominent Rochester researchers shared the state of their research and their experiences discovering and developing useful drugs. Mark Noble, Ph.D., (Biomedical Genetics), Paul Dunman, Ph.D. (Microbiology & Immunology), Harold Smith, Ph.D. (Biochemistry & Biophysics), and Richard Phipps, Ph.D. (Environmental Medicine) all spoke about some

UR Ventures Has Moved!

UR Ventures Has Moved!

in

As of Wednesday, 17 September 2014 UR Ventures has moved to a new location in the Saunders Research Building. We have kept our mailing address, all of our phone numbers, and e-mail addresses. The only difference is our physical location — SRB suite B360. The

43 North Announces Semi-Finalists (Spoiler: this is the fourth connected to UR technologies)

43 North Announces Semi-Finalists (Spoiler: this is the fourth connected to UR technologies)

in

Recently, 113 semi-finalists were announced in the 2014 43 North $1 million business plan competition. Ten of those semi-finalists are from the Rochester area. Four of those are connected to University of Rochester technologies. Health Care Originals (Rochester, NY) is negotiating a license for a

43 North Announces Semi-Finalists (Spoiler: this is #3 connected to UR technologies)

43 North Announces Semi-Finalists (Spoiler: this is #3 connected to UR technologies)

in

Recently, 113 semi-finalists were announced in the 2014 43 North $1 million business plan competition. Ten of those semi-finalists are from the Rochester area. Four of those are connected to University of Rochester technologies. Ovitz Corporation (West Henrietta, NY) intends to develop and commercialize a

43 North Announces Semi-Finalists (Spoiler: this one’s connected to UR technologies, too)

43 North Announces Semi-Finalists (Spoiler: this one’s connected to UR technologies, too)

in

Recently, 113 semi-finalists were announced in the 2014 43 North $1 million business plan competition. Ten of those semi-finalists are from the Rochester area. Four of those are connected to University of Rochester technologies. Raland Therapeutics, Inc. (Fairport, NY) has licensed three technologies from the